1063734-78-0 Usage
Description
(S)-2-(ethylamino)-2-phenylethanol, a chiral chemical compound with the molecular formula C12H17NO, is distinguished by its chiral center, resulting in a pair of enantiomers. It is a versatile intermediate in the synthesis of pharmaceuticals and fine chemicals, playing a crucial role in the production of chiral drugs and serving as a chiral auxiliary in asymmetric synthesis. Its ability to induce and catalyze asymmetric reactions makes it a valuable asset in the pharmaceutical and chemical industries.
Uses
Used in Pharmaceutical Industry:
(S)-2-(ethylamino)-2-phenylethanol is used as an intermediate in the synthesis of pharmaceuticals for its ability to facilitate the production of chiral drugs. Its chiral properties are essential in creating drugs with specific biological activities, ensuring targeted therapeutic effects.
Used in Chemical Industry:
(S)-2-(ethylamino)-2-phenylethanol is used as a chiral auxiliary in asymmetric synthesis for its capacity to induce and catalyze asymmetric reactions. This application is vital in the creation of enantiomerically pure compounds, which are crucial for the development of high-quality fine chemicals and specialty products.
Used in Asymmetric Reactions:
(S)-2-(ethylamino)-2-phenylethanol is used as a catalyst in asymmetric reactions to achieve enantioselective synthesis. Its chiral nature allows for the preferential formation of one enantiomer over the other, which is critical in producing compounds with desired properties and minimizing unwanted side effects in pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1063734-78-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,3,7,3 and 4 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1063734-78:
(9*1)+(8*0)+(7*6)+(6*3)+(5*7)+(4*3)+(3*4)+(2*7)+(1*8)=150
150 % 10 = 0
So 1063734-78-0 is a valid CAS Registry Number.
